https://www.moneycontrol.com/news/business/markets/gland-pharma-gets-eir-from-usfda-for-hyderabad-facility-shares-recover-11429451.html
0
0
26 words
0
Comments
This was a Pre-Approval Inspection (PAI) 7 products and Good Manufacturing Practice (GMP).
You are the first to view
Create an account or login to join the discussion